Skip to content
MS
Sign in
Single-pathway Pathway metabolite unreviewed

Bilirubin diglucuronide

0
Pathways
0
Categories
0
As substrate
0
As product
What can this become? Show on map

Reactions involving Bilirubin diglucuronide

Every recorded step where this molecule takes part

All 1 Consumed 0 Produced 1

Showing all 1 reactions.

Recent literature

Refresh

Europe PMC · from cache · sorted by publication date

  1. 1
    Multimodal optical system for quantitative discrimination of bilirubin species.

    Zwicky J, Fehr D, Albert I, Lehmann S, Witthauer L, Bonmarin M. · 2026-02-18

    cited 1× open access unreviewed
  2. 2
    Risk Assessment for Drug-Induced Hyperbilirubinemia: A Mechanistic Approach.

    Kumar R, Kumar A, Alam A, Mundkur Y, Wingrove J. · 2026-03-01

    cited 1× open access unreviewed
  3. 3
    Disrupted terminal bilirubin catabolism links <i>Lachnospiraceae</i> depletion to inflammatory bowel disease.

    Sabti O, Lialin-Tzadikov K, Ivanova V, Dori-Bachash M, Uzi-Gavrilov S, Tik Z, Mashiach R, Zorea A, Mizrahi I,… · 2026-08-17

    open access unreviewed
  4. 4
    Under Chronic, High-Dose Administration of Wenjing Decoction, the Activation of the Hepatic Nrf2/HO-1 Pathway Mediates Increased Bilirubin Levels and Associated Reversible Neurologic Dysfunction in Mice.

    Du W, Wang M, Song X, Zhang P, Mei X, Luo J, Lan B, Huang S. · 2026-08-12

    open access unreviewed
  5. 5
    Conjugated bilirubin in chronic liver disease: an underutilised prognostic biomarker?-a narrative review.

    Fawcett E, Aravinthan AD. · 2026-02-26

    open access unreviewed
  6. 6
    Dynamic relationships between bilirubin concentrations and the gut microbiota in the neonatal period: A pilot prospective cohort study.

    Li Z, Zhang Y, Luo X, Wang Y, Peng L, Zou L. · 2025-12-05

    open access unreviewed
  7. 7
    Heme in Bacterial Pathogenesis and as an Antimicrobial Target.

    Chen PY, Skaar EP. · 2025-11-17

    cited 9× open access unreviewed
  8. 8
    Stimulation of Skin Pigmentation with UVR Is a Risk Factor for Cholelithiasis.

    Pavel S, Riley PA. · 2025-08-25

    open access unreviewed
  9. 9
    Insights from Metabolomics Profiling of MSUD in Pediatrics Toward Disease Progression.

    Alotaibi AZ, AlMalki RH, Sebaa R, Al Mogren M, Alanazi M, Sumaily KM, Alodaib A, Mujamammi AH, Jacob M, Sabi … · 2025-10-04

    open access unreviewed
  10. 10
    OATP1B1/1B3 deficiency exacerbates hyperbilirubinemia in erythropoietic protoporphyria.

    Gu R, Qin FY, Wang L, Zhang J, Emerson J, Ma Q, Lu J, Anderson KE, Wang J, Ma X. · 2025-05-27

    cited 2× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.